List of Tables
Table 1. Global Glutamate Antagonist Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Glutamate Antagonist Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Glutamate Antagonist Market Competitive Situation by Manufacturers in 2024
Table 4. Global Glutamate Antagonist Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Glutamate Antagonist Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Glutamate Antagonist Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Glutamate Antagonist Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Glutamate Antagonist Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Glutamate Antagonist, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Glutamate Antagonist, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Glutamate Antagonist, Product Type & Application
Table 12. Global Key Manufacturers of Glutamate Antagonist, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Glutamate Antagonist by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glutamate Antagonist as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Glutamate Antagonist Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Glutamate Antagonist Sales by Region (2020-2025) & (K Units)
Table 18. Global Glutamate Antagonist Sales Market Share by Region (2020-2025)
Table 19. Global Glutamate Antagonist Sales by Region (2026-2031) & (K Units)
Table 20. Global Glutamate Antagonist Sales Market Share by Region (2026-2031)
Table 21. Global Glutamate Antagonist Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Glutamate Antagonist Revenue Market Share by Region (2020-2025)
Table 23. Global Glutamate Antagonist Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Glutamate Antagonist Revenue Market Share by Region (2026-2031)
Table 25. North America Glutamate Antagonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Glutamate Antagonist Sales by Country (2020-2025) & (K Units)
Table 27. North America Glutamate Antagonist Sales by Country (2026-2031) & (K Units)
Table 28. North America Glutamate Antagonist Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Glutamate Antagonist Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Glutamate Antagonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Glutamate Antagonist Sales by Country (2020-2025) & (K Units)
Table 32. Europe Glutamate Antagonist Sales by Country (2026-2031) & (K Units)
Table 33. Europe Glutamate Antagonist Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Glutamate Antagonist Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Glutamate Antagonist Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Glutamate Antagonist Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Glutamate Antagonist Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Glutamate Antagonist Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Glutamate Antagonist Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Glutamate Antagonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Glutamate Antagonist Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Glutamate Antagonist Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Glutamate Antagonist Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Glutamate Antagonist Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Glutamate Antagonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Glutamate Antagonist Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Glutamate Antagonist Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Glutamate Antagonist Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Glutamate Antagonist Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Glutamate Antagonist Sales (K Units) by Type (2020-2025)
Table 51. Global Glutamate Antagonist Sales (K Units) by Type (2026-2031)
Table 52. Global Glutamate Antagonist Sales Market Share by Type (2020-2025)
Table 53. Global Glutamate Antagonist Sales Market Share by Type (2026-2031)
Table 54. Global Glutamate Antagonist Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Glutamate Antagonist Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Glutamate Antagonist Revenue Market Share by Type (2020-2025)
Table 57. Global Glutamate Antagonist Revenue Market Share by Type (2026-2031)
Table 58. Global Glutamate Antagonist Price (US$/Unit) by Type (2020-2025)
Table 59. Global Glutamate Antagonist Price (US$/Unit) by Type (2026-2031)
Table 60. Global Glutamate Antagonist Sales (K Units) by Application (2020-2025)
Table 61. Global Glutamate Antagonist Sales (K Units) by Application (2026-2031)
Table 62. Global Glutamate Antagonist Sales Market Share by Application (2020-2025)
Table 63. Global Glutamate Antagonist Sales Market Share by Application (2026-2031)
Table 64. Global Glutamate Antagonist Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Glutamate Antagonist Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Glutamate Antagonist Revenue Market Share by Application (2020-2025)
Table 67. Global Glutamate Antagonist Revenue Market Share by Application (2026-2031)
Table 68. Global Glutamate Antagonist Price (US$/Unit) by Application (2020-2025)
Table 69. Global Glutamate Antagonist Price (US$/Unit) by Application (2026-2031)
Table 70. Artemis Neuroscience Company Information
Table 71. Artemis Neuroscience Description and Business Overview
Table 72. Artemis Neuroscience Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Artemis Neuroscience Glutamate Antagonist Product
Table 74. Artemis Neuroscience Recent Developments/Updates
Table 75. VistaGen Therapeutics Company Information
Table 76. VistaGen Therapeutics Description and Business Overview
Table 77. VistaGen Therapeutics Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. VistaGen Therapeutics Glutamate Antagonist Product
Table 79. VistaGen Therapeutics Recent Developments/Updates
Table 80. Rottapharm Madaus Company Information
Table 81. Rottapharm Madaus Description and Business Overview
Table 82. Rottapharm Madaus Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Rottapharm Madaus Glutamate Antagonist Product
Table 84. Rottapharm Madaus Recent Developments/Updates
Table 85. Amorsa Therapeutics Company Information
Table 86. Amorsa Therapeutics Description and Business Overview
Table 87. Amorsa Therapeutics Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Amorsa Therapeutics Glutamate Antagonist Product
Table 89. Amorsa Therapeutics Recent Developments/Updates
Table 90. Newron Pharmaceuticals Company Information
Table 91. Newron Pharmaceuticals Description and Business Overview
Table 92. Newron Pharmaceuticals Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Newron Pharmaceuticals Glutamate Antagonist Product
Table 94. Newron Pharmaceuticals Recent Developments/Updates
Table 95. Purdue Biopharma Company Information
Table 96. Purdue Biopharma Description and Business Overview
Table 97. Purdue Biopharma Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Purdue Biopharma Glutamate Antagonist Product
Table 99. Purdue Biopharma Recent Developments/Updates
Table 100. Relmada Therapeutics Company Information
Table 101. Relmada Therapeutics Description and Business Overview
Table 102. Relmada Therapeutics Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Relmada Therapeutics Glutamate Antagonist Product
Table 104. Relmada Therapeutics Recent Developments/Updates
Table 105. BioCrea GmbH Company Information
Table 106. BioCrea GmbH Description and Business Overview
Table 107. BioCrea GmbH Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. BioCrea GmbH Glutamate Antagonist Product
Table 109. BioCrea GmbH Recent Developments/Updates
Table 110. Cerecor Inc. Company Information
Table 111. Cerecor Inc. Description and Business Overview
Table 112. Cerecor Inc. Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Cerecor Inc. Glutamate Antagonist Product
Table 114. Cerecor Inc. Recent Developments/Updates
Table 115. NeurOp Inc. Company Information
Table 116. NeurOp Inc. Description and Business Overview
Table 117. NeurOp Inc. Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. NeurOp Inc. Glutamate Antagonist Product
Table 119. NeurOp Inc. Recent Developments/Updates
Table 120. UCB SA Company Information
Table 121. UCB SA Description and Business Overview
Table 122. UCB SA Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. UCB SA Glutamate Antagonist Product
Table 124. UCB SA Recent Developments/Updates
Table 125. Novartis AG Company Information
Table 126. Novartis AG Description and Business Overview
Table 127. Novartis AG Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Novartis AG Glutamate Antagonist Product
Table 129. Novartis AG Recent Developments/Updates
Table 130. Luc Therapeutics Inc. Company Information
Table 131. Luc Therapeutics Inc. Description and Business Overview
Table 132. Luc Therapeutics Inc. Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Luc Therapeutics Inc. Glutamate Antagonist Product
Table 134. Luc Therapeutics Inc. Recent Developments/Updates
Table 135. Evotec AG Company Information
Table 136. Evotec AG Description and Business Overview
Table 137. Evotec AG Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Evotec AG Glutamate Antagonist Product
Table 139. Evotec AG Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Glutamate Antagonist Distributors List
Table 143. Glutamate Antagonist Customers List
Table 144. Glutamate Antagonist Market Trends
Table 145. Glutamate Antagonist Market Drivers
Table 146. Glutamate Antagonist Market Challenges
Table 147. Glutamate Antagonist Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Glutamate Antagonist
Figure 2. Global Glutamate Antagonist Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Glutamate Antagonist Market Share by Type: 2024 & 2031
Figure 4. Ionic Product Picture
Figure 5. Non Ionic Product Picture
Figure 6. Global Glutamate Antagonist Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Glutamate Antagonist Market Share by Application: 2024 & 2031
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Laboratory
Figure 11. Others
Figure 12. Global Glutamate Antagonist Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Glutamate Antagonist Market Size (2020-2031) & (US$ Million)
Figure 14. Global Glutamate Antagonist Sales (2020-2031) & (K Units)
Figure 15. Global Glutamate Antagonist Average Price (US$/Unit) & (2020-2031)
Figure 16. Glutamate Antagonist Report Years Considered
Figure 17. Glutamate Antagonist Sales Share by Manufacturers in 2024
Figure 18. Global Glutamate Antagonist Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Glutamate Antagonist Players: Market Share by Revenue in Glutamate Antagonist in 2024
Figure 20. Glutamate Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Glutamate Antagonist Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Glutamate Antagonist Sales Market Share by Country (2020-2031)
Figure 23. North America Glutamate Antagonist Revenue Market Share by Country (2020-2031)
Figure 24. United States Glutamate Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Glutamate Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Glutamate Antagonist Sales Market Share by Country (2020-2031)
Figure 27. Europe Glutamate Antagonist Revenue Market Share by Country (2020-2031)
Figure 28. Germany Glutamate Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Glutamate Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Glutamate Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Glutamate Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Glutamate Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Glutamate Antagonist Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Glutamate Antagonist Revenue Market Share by Region (2020-2031)
Figure 35. China Glutamate Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Glutamate Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Glutamate Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Glutamate Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Glutamate Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Glutamate Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Glutamate Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Glutamate Antagonist Sales Market Share by Country (2020-2031)
Figure 43. Latin America Glutamate Antagonist Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Glutamate Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Glutamate Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Glutamate Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Glutamate Antagonist Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Glutamate Antagonist Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Glutamate Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Glutamate Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Glutamate Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Glutamate Antagonist by Type (2020-2031)
Figure 53. Global Revenue Market Share of Glutamate Antagonist by Type (2020-2031)
Figure 54. Global Glutamate Antagonist Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Glutamate Antagonist by Application (2020-2031)
Figure 56. Global Revenue Market Share of Glutamate Antagonist by Application (2020-2031)
Figure 57. Global Glutamate Antagonist Price (US$/Unit) by Application (2020-2031)
Figure 58. Glutamate Antagonist Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
